Trial Profile
A Multi-Center, Randomized Controlled Trial Comparing The Clinical Effectiveness and Cost-Effectiveness of Collagenase Injection (Xiaflex) and Palmar Fasciectomy in the Management of Dupuytren's Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Jul 2023
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Dupuytren's contracture
- Focus Therapeutic Use
- Acronyms EXTEND
- 23 Dec 2021 Status changed from active, no longer recruiting to completed.
- 20 May 2021 Planned End Date changed from 1 Dec 2021 to 1 Nov 2021.
- 20 May 2021 Planned primary completion date changed from 1 Jul 2021 to 1 Nov 2021.